Holt Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Buy |
1,952
+222
| +13% | +$225K | 0.24% | 65 |
|
|
2025
Q4 | $1.86M | Buy |
1,730
+20
| +1% | +$19.1K | 0.25% | 64 |
|
|
2025
Q3 | $1.3M | Buy |
1,710
+20
| +1% | +$14.9K | 0.21% | 72 |
|
|
2025
Q2 | $1.32M | Hold |
1,690
| – | – | 0.23% | 69 |
|
|
2025
Q1 | $1.4M | Buy |
1,690
+25
| +2% | +$20.8K | 0.21% | 74 |
|
|
2024
Q4 | $1.29M | Buy |
1,665
+620
| +59% | +$513K | 0.19% | 78 |
|
|
2024
Q3 | $926K | Hold |
1,045
| – | – | 0.14% | 93 |
|
|
2024
Q2 | $946K | Buy |
1,045
+625
| +149% | +$500K | 0.2% | 74 |
|
|
2024
Q1 | $327K | Sell |
420
-625
| -60% | -$445K | 0.05% | 133 |
|
|
2023
Q4 | $609K | Buy |
1,045
+645
| +161% | +$376K | 0.11% | 106 |
|
|
2023
Q3 | $215K | Sell |
400
-656
| -62% | -$338K | 0.04% | 146 |
|
|
2023
Q2 | $495K | Buy |
+1,056
| New | +$443K | 0.09% | 113 |
|
|
2023
Q1 | – | Sell |
-920
| Closed | -$337K | – | 156 |
|
|
2022
Q4 | $337K | Buy |
+920
| New | +$326K | 0.07% | 125 |
|
|
2022
Q3 | – | Sell |
-645
| Closed | -$209K | – | 147 |
|
|
2022
Q2 | $209K | Buy |
+645
| New | +$194K | 0.04% | 153 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | -$7K | – | 160 |
|
|
2016
Q1 | $7K | Buy |
+100
| New | +$7.57K | ﹤0.01% | 217 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$8K | – | 156 |
|
|
2015
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 225 |
|
|
2015
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 229 |
|
|
2015
Q1 | $7K | Hold |
100
| – | – | ﹤0.01% | 231 |
|
|
2014
Q4 | $7K | Buy |
+100
| New | +$6.75K | ﹤0.01% | 235 |
|
Other funds holding LLY
VCM
VPM
